^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Preclinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T cells for the Treatment of Acute Myeloid Leukemia

Published date:
02/02/2021
Excerpt:
B7-H3 is expressed on monocytic AML cell lines and on primary AML blasts from patients with monocytic AML...B7-H3.CAR-Ts exhibit efficient antigen-dependent cytotoxicity in vitro and in xenograft models of AML, and are unlikely to cause unacceptable hematopoietic toxicity.
DOI:
10.1158/1078-0432.CCR-20-2540